SlideShare a Scribd company logo
1 of 94
MBSM 713: BIOCHEMISTRY OF ANTI
MICROBIAL AGENTS
Lecture Two:
Survey of major antimicrobial
drug groups
1.ANTIBACTERIAL AGENTS
(Antibiotics)
Dr. G. Kattam Maiyoh
01/23/15 1
GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Classification: Mode of action
01/23/15 2
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Inhibitors of Cell Wall Synthesis
01/23/15 3
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
01/23/15 4
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Bacterial cell wall
• There are three types
– Gram-positive (e.g. Staphylococci,
Listeria
• Have many peptidoglycan
layers
• stains with crystal violet
• typically lack the outer
membrane found in gram-ve.
– Gram-negative (e.g. E.coli,
Salmonella)
• Have few peptidoglycan layers
• (stain safranin or fuchsin)
– Acid-fast Positive (Mycobacteria)
• Cell wall contains waxy
substance (Mycollic acid)
• Stains with acid fast (heating
required)
Antibiotics - Cell wall synthesis inhibitors
Beta-lactam antibiotics:
1928 - Alexander Fleming
observes the
antibacterial effects of
Penicillin
1940 - Florey and Chain
extract Penicillin
01/23/15 5
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
The beta lactams
• The β-lactam group of antibiotics
includes an enormous diversity of
natural and semi-synthetic
compounds that inhibit several
enzymes associated with the final
step of peptidoglycan synthesis.
• All of this enormous family are
derived from a β -lactam structure: a
four-membered ring in which the β
-lactam bond resembles a peptide
bond.
• The multitude of chemical
01/23/15 6
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
The Beta-Lactams
01/23/15
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
7
R – variable side chain
Monobactam nucleus
Penicillinase (β Lactamase)
- Represents a great challenge to the action of the beta lactams
Figure 20.8
More when we discuss antibiotic resistance
01/23/15 8
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
• Penicillium notatum produces the
only naturally occurring agent –
penicillin G or benzylpenicillin
• Penicillium chrysogenum produces
6-aminopenicillanic acid, raw
material for semi-synthetics
penicillins
01/23/15 9
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Targets for beta lactams
1. The targets for β-lactam drugs are the penicillin binding
proteins (PBP's), so called because they bind radioactive
penicillin and can be detected by autoradiography of gels on
which bacterial proteins have been separated
electrophoretically.
• The penicillin binding proteins have transpeptidase or
carboxypeptidase activity and they act to regulate cell size and
shape.
• They are also involved in septum formation and cell division. Bacteria have
several individual penicillin binding proteins, each with a separate function.
• Conventionally these are numbered according to size, with PBP 1 as the
largest protein.
• The PBP 1 of one bacterium will not necessarily have the same function as
the PBP 1 of a different organism.
01/23/15 10
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Target
2. The β-lactam antibiotics also stimulate the activity of
autolysins by inactivating an inhibitor => lysis
• Autolysins are enzymes that are responsible for the natural
turnover of cell wall polymers to permit growth of the cells.
• Under normal conditions, these enzymes produce
controlled weak points within the peptidoglycan
structure to allow for expansion of the cell wall structure.
• This activity is stimulated by β-lactams, causing a
breakdown of peptidoglycan and leading to osmotic
fragility of the cell and ultimately to cell lysis.
01/23/15 11
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Penicillins - classification
– Narrow spectrum – penicillinase sensitive
– Narrow spectrum – penicillinase resistant
– Broad spectrum penicillins
– Extended-spectrum penicillins
• Cephalosporines
• Carbapenems
• Monobactams
• Vancomycin, Bacitracin
01/23/15 12
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Penicllins (pharmacokinetics)
• Attains therapeutic concentration in
most tissues
• However has poor CSF penetration
• Renal excretion (Excretion)
• Side effects: hypersensitivity, nephritis,
neruotoxicity, platelet dysfunction
01/23/15 14
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Narrow spectrum – penicillinase (= β-lactamase)
sensitive
• Benzylpenicillin
– Naturally occuring
– Poor oral availability (sensitive to stomach acid)
=> given by injection
– Active against gram-positive bacteria
• Phenoxymethylpenicillin
– Better oral availability (acid resistant)
01/23/15 15
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Narrow spectrum – penicillinase (= β-lactamase) resistant
• Methicillin
– Semisynthetic
– Poor oral availability (only parenteral)
– Active against gram-pos bacteria
– Mostly used for Staphylococcus aureus
• Oxacillin
– Good oral availability
• Cloxacillin
• Dicloxacillin
01/23/15 16
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Broad spectrum – penicillinase (β-
lactamase) sensitive
(Also referred to as Aminopenicillins)
• Ampicillin
– Semisynthetic
– Good oral availability
– Active against gram-pos and gram-neg bacteria
– Active against enterobacteria e.g. kleb. Shig. Salm
• Amoxicillin
– Excellent oral availability
01/23/15 17
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Extended spectrum – penicillinase (β-
lactamase) sensitive
(Also called Carboxypenicillins)
• Carbenicillin
– Semisynthetic
– Poor oral availability
– Active against gram-pos and gram-neg bacteria
– Active against Pseudomonas aeruginosa and
Klebsiella
• Ticarcillin
• Mezlocillin
• Pipercillin
01/23/15 18
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Penicillins
Figure 20.6
01/23/15 19
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
01/23/15
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
20
Cephalosporins
• Share the same antibiotic mechanism as penicillins
• Cross-allergies with penicillins are common
• Some CSs antagonize Vitamin K => leads to bleeding
• Some CSs block alcohol oxidation => disulfiram effect (allergic
reactions, seizures, extreme tiredness and dark urine)
Classified into generations: 1- 4
 • Increasing activity against gram-negative bacteria and
anaerobes
• Increasing resistance to destruction by beta-lactamases
• Increasing ability to reach cerebrospinal fluid
01/23/15 21
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Cephalosporins
• The first to be discoverded were called first
generation while later, more extended spectrum
cephalosporins were classified as second, third and
4th generation cephalosporins in this order.
• Each newer generation has significantly greater gram-
negative antimicrobial properties than the preceding
generation,
• Most cases with decreased activity against gram-
positive organisms.
• Fourth generation cephalosporins, however, have true
broad spectrum activity.
01/23/15 22
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
01/23/15 23
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
01/23/15
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
24
Cephalosporin structure
• Base molecule is 7-
aminocephalosporanic acid
produced by a Sardinian
sewer mold
• R groups determine
spectrum of activity and
pharmacological properties
• Mechanism of
action/resistance and class
pharmacology is essentially
the same as penicillins
01/23/15 25
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
First Generation Cephalosporins
• Cefazolin, cephalexin,
cephadroxil
• Excellent against susceptible
staph and strep
• Modest activity against G -ve
• Cefazolin given parentally,
others orally
• More than half of the drug is
bound to plasma proteins
• Excreted by kidneys
unmetabolized
• Good for staph and strep skin
and soft tissue infections
01/23/15 26
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Second Generation Cephalosporins
• Include;
– Cefaclor,
– cefuroxime,
– cefprozil
• Modest activity against G+, increased activity
against G-, works against anaerobes
• Cefaclor and cefprozil given orally
• Absorption and excretion same as first
generation.
• Good for treating respiratory tract infections,
intra-abdominal infections, pelvic
inflammatory disease, diabetic foot ulcers
01/23/15 27
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Third Generation Cephalosporins
• Ceftaxime, ceftriaxzone,
cefoperazone, cefpodoxime
• Broad spectrum killers
• Drugs of choice for serious
infections
• No effect against Listeria and beta-
lactamase producing pneumococci
• Cefpodoxime given orally, others
parentally
• Most excreted by kidney
• Therapeutic uses
– Bacterial meningitis
– Lyme disease
– Life-threatening G -ve sepsis
(infection)
01/23/15 28
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Fourth Generation Cephalosporin
– e.g.Cefepime
–Have true broad spectrum activity ( and
more beta-lactamases resistanc (effective
against Gm+ and Gm-)
–Given parentally, excellent penetration into
CSF
–Good for nosocomial infections
01/23/15 29
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
01/23/15
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
30
Toxicity/Contraindications
of Cephalosporins
• Hypersensitivity reactions (uncommon) essentially
same as for penicillins
• Cross-reaction between 2 classes
01/23/15 31
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Inhibitors of Cell Wall Synthesis
01/23/15 33GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Carbapenems
• Beta-lactam ring is
fused to a 5 member
ring system
• Effect on microbes
and pharmacology
of carbapenems
similar to penicillins
01/23/15 34GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Selected Carbapenems
• Imipenem
– Broad spectrum including anaerobes
and Pseudomonas aeruginosa
– Parentally administered
– Must be combined with cilastatin to be
absorbed
– Excreted by kidneys
• Meropenem, ertapenem, and doripenem
are similar to imipenem but don’t need co-
administration with cilastatin
cilastatin chemical compound which inhibits the human enzyme dehydropeptidase
01/23/15 35GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications
of Carbapenems
• Nausea and vomiting (common)
• Hypersensitivity reactions (uncommon)
– Essentially the same as for penicillins
– Cross-reactivity is possible
01/23/15 36
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Aztrenam – a monobactam
• Monobactam - beta-lactam compounds
wherein the beta-lactam ring is alone and not
fused to another ring
• Works only on Gm -ve, including Pseudomonas
aeruginosa
• Useful for treating G-ve infections that require
a beta-lactam because it does not elicit
hypersensitivity reactions
01/23/15 37GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Beta-lactamase inhibitors
a. Clavulanic acid
– Irreversible inhibitor of β-lactamase
– Good oral absorption
– Combined with amoxicillin or ticarcillin
b. Sulbactam
01/23/15 38GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Peptide Antibiotics
Peptide antibiotics are drugs with
polypeptides structure
Sub-group of Peptide Antibiotics
Polymyxins e.g.
ÂťPolymyxin B
ÂťColistin
Glycopeptides e.g.
ÂťVancomycin
ÂťTeicoplanin
ÂťAvoparcin
Bacitracin
Streptogramins
Each drug group has its own mechanism of
action
4 groups and 4 mechanism
01/23/15 39
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
PolymyxinsPolymyxins
Drug members
Polymyxin B
Colistin (Polymyxin E)
Mechanism of action
Detergent-like action
Damage to cell membrane function
Bind to Lipopolysaccharides (LPS) and
destroy outer membrane of Gram-
negative bacteria
Bactericidal
Concentration-dependent
Non-selective on bacterial membrane
Spectrum of activity
Gram-negative bacteria01/23/15 40
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
PolymyxinsPolymyxins
• Pharmacokinetics
–Not absorbed via GI tract
–If injection, drug accumulated and
slowly excreted
• Toxicities
–Highly toxic if systemic injection
–Nephrotoxic
–Neurotoxic
• Clinical uses
–Oral treatment
–
01/23/15 41
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
GlycopeptidesGlycopeptides
• Group members
–Vancomycin
• Antibacterial activity
–Inhibition of cell wall synthesis
–Active against Gram-positive bacteria
• Not absorbed orally, must
administered IV
• High toxicity
–Local irritation , ototoxicity,
nephrotoxicity
• Clinical uses
–Hardly used in animals01/23/15 42
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
BacitracinBacitracin
• Drug activity
–Inhibit cell wall synthesis
–Activity on Gram-positive bacteria
–Bactericidal
• Nephrotoxic if systemic injection
• Clinical uses – the same as polymyxin
–Oral – as growth promoter
–Local or topical drugs
01/23/15 43
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Antibiotics that Inhibit Protein Synthesis
01/23/15 44
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Protein synthesis inhibitors
– Aminoglycosides
– Tetracyclins
- Spectinomycin
– Macrolides
– Chloramphenicol
– Clindamycin
01/23/15
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
45
Inhibition of Protein Synthesis by Antibiotics
Figure 20.4
01/23/15 46
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Review of Initiation of Protein Synthesis
30S
1 3
2 GTP
1 2 3 GTP
Initiation Factors
mRNA
3
1
2 GTP
30S
Initiation
Complex
f-met-tRNA
Spectinomycin
Aminoglycosides
1
2
GDP + Pi
50S
70S
Initiation
Complex
AP
01/23/15 47
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Review of Elongation of Protein Synthesis
GTP
AP
Tu GTP Tu GDP
Ts
Ts
Tu
+
GDP
Ts
Pi
P ATetracycline
AP
Erythromycin
Fusidic Acid
Chloramphenicol
G GTP
G GDP + Pi
G
GDP
AP
+
GTP
01/23/15 48
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Antimicrobials that Bind to the 30S
Ribosomal Subunit
01/23/15 49
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
a) Aminoglycosides (bactericidal)
streptomycin, kanamycin, gentamicin, tobramycin, amikacin,
netilmicin, neomycin (topical)
• Mode of action - The aminoglycosides irreversibly bind
to the 16S ribosomal RNA and freeze the 30S initiation
complex (30S-mRNA-tRNA) so that no further initiation
can occur.
• They also slow down protein synthesis that has already
initiated and induce misreading of the mRNA.
– By binding to the 16 S r-RNA the aminoglycosides increase
the affinity of the A site for t-RNA regardless of the anticodon
specificity.
• May also destabilize bacterial membranes.
01/23/15 50
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Microbe Library
American Society for Microbiology
www.microbelibrary.org
01/23/15 51
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
b) Aminoglycosides (bactericidal)
streptomycin, kanamycin, gentamicin, tobramycin, amikacin,
netilmicin, neomycin (topical)
• Spectrum of Activity –Effective against many gram-
negative and some gram-positive bacteria;
• Not useful for anaerobic (oxygen required for uptake of
antibiotic) or intracellular bacteria.
• Resistance - Common
• Synergy - The aminoglycosides synergize with β -lactam
antibiotics. The β -lactams inhibit cell wall synthesis and
thereby increase the permeability of the aminoglycosides.
01/23/15 52GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
c) Tetracyclines (bacteriostatic)
tetracycline, minocycline and doxycycline
• Mode of action - The tetracyclines reversibly bind to the 30S
ribosome and inhibit binding of aminoacyl-t-RNA to the acceptor site
on the 70S ribosome.
• Spectrum of activity - Broad spectrum; Useful against intracellular
bacteria
• Resistance - Common
• Adverse effects - Destruction of normal intestinal flora resulting in
increased secondary infections; staining and impairment of the
structure of bone and teeth.
01/23/15 53
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
d) Spectinomycin (bacteriostatic)
• Mode of action - Spectinomycin reversibly interferes with m-RNA
interaction with the 30S ribosome. It is structurally similar to the
aminoglycosides but does not cause misreading of mRNA.
• Spectrum of activity - Used in the treatment of penicillin-resistant
Neisseria gonorrhoeae
• Resistance - Rare in Neisseria gonorrhoeae
01/23/15 54
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Antimicrobials that Bind to the 50S
Ribosomal Subunit
01/23/15 55
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
a) Chloramphenicol, Lincomycin,
Clindamycin (bacteriostatic)
• Mode of action - These antimicrobials bind to the 50S ribosome and
inhibit peptidyl transferase activity.
• Spectrum of activity - Chloramphenicol - Broad range;
Lincomycin and clindamycin - Restricted range
• Resistance - Common
• Adverse effects - Chloramphenicol is toxic (bone marrow suppression) but
is used in the treatment of bacterial meningitis.
01/23/15 56
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
b) Macrolides (bacteriostatic)
erythromycin, clarithromycin, azithromycin, spiramycin
• Mode of action - The macrolides inhibit translocation.
• Spectrum of activity - Gram-positive bacteria,
Mycoplasma, Legionella
• Resistance - Common
01/23/15 57
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Macrolides : ClassificationMacrolides : Classification
• Macrolides are drugs with lactone ring
structure
• Sub-groups are based on no. of ring atom
– 12-membered ring macrolides
– 13-membered
– 14-membered (many drugs)
– 15-membered
– 16-membered (many drugs)
• Special groups
– Azalides – name for 15-membered
– Triamilides – name for tulathromycin
(combination of 13- and 15-membered)
– Ketolides – name for 14-membered with 3
keto group
01/23/15 58
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
MacrolidesMacrolides
Drug examples
13-membered
Tulathromycin (Triamilides)
14-membered
Erythromycin
Clarithromycin, Roxithromycin,
Dirithromycin
15-membered
Azithromycin (Azalides)
Tulathromycin (Triamilides)
16-membered
Spiramycin
Tylosin
01/23/15 59
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Macrolides – generalMacrolides – general
propertiesproperties
• Mechanism of
action
– Inhibit protein
synthesis
– Bind to 50S
ribosomal unit
– Bacteriostatic
• Spectrum of
activity
– Gram-positive
– Some Gram-
negative
01/23/15 60
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
MacrolidesMacrolides
Pharmacokinetics
Broad distribution in body
tissues
High intracellular
concentration
01/23/15 61
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
MacrolidesMacrolides
Additional properties
of Macrolides
• Anti-inflammatory
effect
– Inhibitory effect on
neutrophils
– inhibit
proinflammatory
cytokines
– Useful for treatment
of inflammatory01/23/15 62
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
ErythromycinErythromycin
• Erythromycin is a standard or basic drug of
macrolides
• Other drug members are usually compared
with erythromycin
• Important adverse effect - severe diarrhea
– Especially in adult horse and ruminants
• Clinical uses
– Second choice (alternative drug) in
humans
– Small animals
– Fowls
01/23/15 63
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Tylosin andTylosin and SpiramycinSpiramycin
• Tylosin and Spiramycin
– Activities are similar
to erythromycin
– Good activity on
Mycoplasma
• Examples of Clinical
uses
– Whooping couph
– Pneumonia
– VDs
– Used in ruminants01/23/15 64
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Advanced generationAdvanced generation
MacrolidesMacrolides
Example drugs
Roxithromycin
Dirithromycin
Clarithromycin
Azithromycin
General activity – the same as erythromycin
Better Pharmacokinetic properties
Acid stable
Fewer GI side effect
Higher oral availability
Longer serum half-lives
Higher tissue concentrations
01/23/15 65
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
KetolidesKetolides
• Ketolides are 14-
membered ring
macrolides with 3
keto group
• Specific drugs
– Telithromycin
– Cethromycin (still
in clinical study)
• Important
properties
– Less resistance
– Good activities on01/23/15 66
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Fusidic acid (bacteriostatic)
• Selectivity due to differences in prokaryotic and
eukaryotic elongation factors
• Mode of action - Fusidic acid binds to elongation
factor G (EF-G) and inhibits release of EF-G from the
EF-G/GDP complex.
• Spectrum of activity - Gram-positive cocci
01/23/15 67GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Antimicrobials that Interfere with
Elongation Factors
Inhibitors of Nucleic Acid Synthesis
~Inhibitors of DNA synthesis
~Inhibitors of RNA synthesis
01/23/15 69
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Inhibitors of RNA Synthesis
For this class of antibiotics, selectivity is due to
differences between prokaryotic and eukaryotic RNA
polymerase i.e.
All RNA polymerases are multi-protein complexes,
however, the number of proteins that are assembled
to form the active enzyme is much larger in eukaryotes;
•The basic catalytic core is made up of 12 subunits.
•By comparison, bacterial RNAP has 5 subunits.
01/23/15 70
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Rifampin, Rifamycin, Rifampicin, Rifabutin
(bactericidal)
• Mode of action - These antimicrobials bind to DNA-dependent RNA
polymerase and inhibit initiation of mRNA synthesis.
• Spectrum of activity - Broad spectrum but is used most commonly
in the treatment of tuberculosis
• Resistance – Common
– For example;
– Resistance to rifampicin develops quickly during treatment, so
monotherapy should not be used to treat these infections — it
should be used in combination with other antibiotics.
– Resistance to rifampicin arises from mutations that alter
residues of the rifampicin binding site on RNA polymerase,
resulting in decreased affinity for rifampicin.
• Combination therapy - Since resistance is common, rifampin is
usually used in combination therapy.
01/23/15 71
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Inhibitors of DNA Synthesis
For this class of antibiotics, selectivity due to differences between prokaryotic
and eukaryotic DNA replication enzymes
Consider the following:
Eukaryotic replication is more complicated.
•First, they have multiple ori per chromosome that allow for
bidirectional synthesis of the linear chromosome.
•They also use several DNA polymerases (I, II, III), and ligase (seals the
nicks in the DNA strand), and RNA primer (gives a 3' end for the DNA
polymerase to start synthesis).
•As for other differences in their synthesis of DNA is their speed,
prokaryotes can replicate their chromosome at about 1,000 bp/sec, while
eukaryotes can replicate their chromosomes at about 100 bp/sec.
•They also differ in the number of ori, eukaryotes (as it was stated above)
has multiple ori, while prokaryotes have only one.
01/23/15 72
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
The Quinolones
• Current drugs are
fluoridated 4-quinolones
• Broad coverage (some
broader than others)
• Targets DNA gyrase ( G-)
and topoisomerase IV
(G+)
• Resistance due to efflux
and mutations in targets
01/23/15 73
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Pharmacological attributes of Quinolones
• Favorable pharmacological attributes
– Orally administered, quickly absorbed,
even with a full stomach
– Excellent bioavailability in a wide
range of tissues and body fluids
(including inside cells)
• Mostly cleared by the kidneys
– Exceptions are pefloxacin and
moxifloxacin which are metabolized by
liver
• Ciprofloxacin, ofloxacin, and pefloxacin
are excreted in breast milk
““Got Cipro?”Got Cipro?”
01/23/15 74
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses
of Quinolones
• Urinary tract
infections
• Prostatitis
• STD’s
– Chlamydia
– Chancroid - painful
sores on the genitalia
– Not syphilis or
gonorrhea (due to
increased resistance)
01/23/15 75
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses of Quinolones
• GI and abdominal
– Travelers diarrhea
– Shigellosis
– Typhoid fever
• Respiratory tract
– New agents for strep. pneumonia
01/23/15 76
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses
of Quinolones
• Bone, joint, soft tissue
– Ideal for chronic
osteomylitis - infection of
the bone or bone marrow
• Resistance developing in
S. aureus, P. aeruginosa,
and S. marcesens
– Good against
polymicrobial infections
like diabetic foot ulcers
01/23/15 77
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses
of Quinolones
• Ciprofloxacin for anthrax
and tuleremia (rabbit fever, deer
fly fever, Ohara's fever)
• Combined with other drugs,
useful for atypical
Mycobacterium sp.
Pulmonary AnthraxPulmonary Anthrax
01/23/15 78
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications of Quinolones
• Nausea, vomiting, abdominal discomfort (common)
• Diarrhea and antibiotic-associated colitis (uncommon to rare)
• CNS side effects
– Mild headache and dizziness (common to rare)
– Hallucinations, delirium, and seizures (rare)
• Arthropy in immature animals (common)
– Quinolones not given to children unless benefits outweigh the risks
• Leukopenia, eosinophilia, heart arythmias (rare)
delirium - disorder involving incoherent speech, hallucinations, etc., caused by
intoxication, fever, etc
01/23/15 79
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Antimetabolite Antibiotics
01/23/15 80
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Inhibitors of Folic Acid Synthesis
• Basis of Selectivity
• Review of Folic
Acid Metabolism
p-aminobenzoic acid + Pteridine
Dihydropteroic acid
Dihydrofolic acid
Tetrahydrofolic acid
Pteridine
synthetase
Dihydrofolate
synthetase
Dihydrofolate
reductase
Thymidine
Purines
Methionine
Trimethoprim
Sulfonamides
01/23/15 81
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Sulfonamides, Sulfones (bacteriostatic)
• Mode of action - These antimicrobials are analogues of para-
aminobenzoic acid and competitively inhibit formation of
dihydropteroic acid.
• Spectrum of activity - Broad range activity against gram-
positive and gram-negative bacteria; used primarily in urinary
tract and Nocardia infections.
• Resistance - Common
• Combination therapy - The sulfonamides are used in
combination with trimethoprim; this combination blocks two
distinct steps in folic acid metabolism and prevents the
emergence of resistant strains.
01/23/15 82
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Trimethoprim, Methotrexate,
Pyrimethamine (bacteriostatic)
• Mode of action - These antimicrobials binds to dihydrofolate
reductase and inhibit formation of tetrahydrofolic acid.
• Spectrum of activity - Broad range activity against gram-
positive and gram-negative bacteria; used primarily in urinary
tract and Nocardia infections.
• Resistance - Common
• Combination therapy - These antimicrobials are used in
combination with the sulfonamides; this combination blocks
two distinct steps in folic acid metabolism and prevents the
emergence of resistant strains.
01/23/15 83
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Sulfonamides
• Analogues of para-aminobenzoic
acid
• Broad spectrum
• Competitive inhibitors of
dihydropteroate synthase – needed
for folic acid synthesis
Gerhard Domagk gets a NobelGerhard Domagk gets a Nobel
for Medicine, 1939.for Medicine, 1939.
01/23/15 84
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Sulfonamides
• Mostly absorbed from GI tract
• Binds variably to serum albumin
• Wide tissue distribution, including
transplacentally
• Variably inactivated in liver by
acetylation and then excreted in
urine
• Some agents can precipitate in acid
urine
01/23/15 85
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
1. Rapidly Absorbed and Eliminated
Sulfonamides
• Sulfisoxazole,
sulfamethoxazole, sulfadiazine
• Bind extensively to plasma
proteins
• Highly concentrated in urine
(cidal)
• Sulfamethoxazole combined
with trimethoprim (Bactrim) is
widely used to treat a variety
of infections (esp. UTI)
01/23/15 86
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
2. Poorly Absorbed Sulfonamides
• E.g. Sulfasalazine
• Poorly absorbed in GI tract
• Used to treat ulcerative colitis
and irritable bowel syndrome
• Gut flora metabolize drug into
2 compounds, 1 toxic-
sulfapyridine, 1 therapeutic
(5-aminosalicylate)
• Hence is a prodrug – effective
after breakdown
Ulcerative Colitis
01/23/15 87
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Sulfonamides for Topical Use
• E.g. 1.Sulfacetamide
– Good penetration in eye
– Non-irritating
• 2. Silver sulfadiazine
– Prevention and treatment of
burn wound infections
Bacterial corneal infectionBacterial corneal infection
01/23/15 88
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Long Acting Sulfonamide
• Serum half-life is
measured in days rather
than minutes or hours
• E.g. Sulfadoxine
• Combined with
pyirethamine to treat
malaria
Plasmodium vivaxPlasmodium vivax
01/23/15 89
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses of Sulfonamides
• Urinary tract infections
• Nocardiosis -serious infection
caused by a fungus-like bacterium
that begins in the lungs and can
spread to the brain.
• Toxoplasmosis - caused
by protozoan (avoid using in
pregnant women)
Nocardia asteroidesNocardia asteroides
01/23/15 90
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications
of Sulfonamides - UT
• Crystallization in acid
urine
– Common to uncommon
depending on drug.
– Alkalize urine or increase
hydration
01/23/15 91
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications
of Sulfonamides - blood
• Acute hemolytic anemia
– Rare to extremely rare
– Associated with glucose-6-phosphate
dehydrogenase activity in RBC
• Agranulocytosis - failure of the bone marrow to make enough white
blood cells (neutrophils). (extremely rare)
• Aplastic anemia - marrow doesn't make enough new blood cells.
(extremely rare)
01/23/15 92
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications
of Sulfonamides - immune
• Hypersensitivity reactions
(common to uncommon)
– Skin and mucous membrane
manifestations (rashes)
– Serum sickness - type III hypersensitivity
reaction that results from the injection of
heterologous or foreign protein or serum
– Focal or diffuse necrosis of the liver
(rare)
01/23/15 93
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxic Epidermal Necrolysis (TEN)
01/23/15 94
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications
of Sulfonamides - miscellaneous
• Nausea, anorexia, vomiting
(common)
• Kernicterus; damage caused by
excessive jaundice
– Displacement of bilirubin from
plasma albumin to brain
resulting in
encephalopathy(disease of
the brain)
– Never give sulfa drugs to a
pregnant or lactating woman
• Potentiation of oral coagulants,
sulfonylurea hypoglycemic drugs,
and hydrantoin anticonvulsants
Bilirubin deposits in neonatalBilirubin deposits in neonatal
brainbrain
01/23/15 95
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
INJURY TO THE PLASMA MEMBRANE - Brief
• All cells are bound by a cell membrane.
• And although the membranes of all cells are quite
similar, those of bacteria and fungi differ from
eukaryotic cells.
• These slight differences allow for selective action of
some antimicrobial agents.
• Certain antibiotics, like polymyxins, act as detergents
to dissolve bacterial cell membranes by binding to
phospholipids present in the membranes.
01/23/15
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
96
The End
Thank you for Listening
01/23/15
GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
97

More Related Content

What's hot (20)

Antimicrobial agents
Antimicrobial agentsAntimicrobial agents
Antimicrobial agents
 
Spectrum of commonly used antibiotics
Spectrum of commonly used antibioticsSpectrum of commonly used antibiotics
Spectrum of commonly used antibiotics
 
Penicillins (ANTIBIOTICS)
Penicillins (ANTIBIOTICS)Penicillins (ANTIBIOTICS)
Penicillins (ANTIBIOTICS)
 
Fluoroquinolones
Fluoroquinolones Fluoroquinolones
Fluoroquinolones
 
Antifungal agents
Antifungal agentsAntifungal agents
Antifungal agents
 
Beta Lactam Antibiotics
Beta Lactam Antibiotics Beta Lactam Antibiotics
Beta Lactam Antibiotics
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Penicillins (VK)
Penicillins (VK)Penicillins (VK)
Penicillins (VK)
 
Anti-Fungal drugs
Anti-Fungal drugsAnti-Fungal drugs
Anti-Fungal drugs
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
 
2.ANTIBIOTIC (CELL WALL INHIBITORS)
2.ANTIBIOTIC (CELL WALL INHIBITORS)2.ANTIBIOTIC (CELL WALL INHIBITORS)
2.ANTIBIOTIC (CELL WALL INHIBITORS)
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
Cephalosporin Antibiotics
Cephalosporin AntibioticsCephalosporin Antibiotics
Cephalosporin Antibiotics
 
Beta lactamase inhibitors
Beta lactamase inhibitorsBeta lactamase inhibitors
Beta lactamase inhibitors
 
Antimicrobial drugs,,,,,
Antimicrobial drugs,,,,,Antimicrobial drugs,,,,,
Antimicrobial drugs,,,,,
 
Penicillins
PenicillinsPenicillins
Penicillins
 
Superinfection
SuperinfectionSuperinfection
Superinfection
 

Viewers also liked

Optimization techniques in pharmaceutical formulation and processing
Optimization techniques in pharmaceutical formulation and processingOptimization techniques in pharmaceutical formulation and processing
Optimization techniques in pharmaceutical formulation and processingReshma Fathima .K
 
Optimization Techniques In Pharmaceutical Formulation & Processing
Optimization Techniques In Pharmaceutical Formulation & ProcessingOptimization Techniques In Pharmaceutical Formulation & Processing
Optimization Techniques In Pharmaceutical Formulation & ProcessingAPCER Life Sciences
 
Optimization techniques
Optimization techniquesOptimization techniques
Optimization techniqueskunal9689176018
 
Optimization techniques in pharmaceutical processing
Optimization techniques in pharmaceutical processingOptimization techniques in pharmaceutical processing
Optimization techniques in pharmaceutical processingNaval Garg
 

Viewers also liked (6)

Nucleophilic Substitution
Nucleophilic SubstitutionNucleophilic Substitution
Nucleophilic Substitution
 
Optimization techniques in pharmaceutical formulation and processing
Optimization techniques in pharmaceutical formulation and processingOptimization techniques in pharmaceutical formulation and processing
Optimization techniques in pharmaceutical formulation and processing
 
Optimization Techniques In Pharmaceutical Formulation & Processing
Optimization Techniques In Pharmaceutical Formulation & ProcessingOptimization Techniques In Pharmaceutical Formulation & Processing
Optimization Techniques In Pharmaceutical Formulation & Processing
 
Optimization techniques
Optimization techniquesOptimization techniques
Optimization techniques
 
Optimization techniques in pharmaceutical processing
Optimization techniques in pharmaceutical processingOptimization techniques in pharmaceutical processing
Optimization techniques in pharmaceutical processing
 
Substitution reactions
Substitution reactionsSubstitution reactions
Substitution reactions
 

Similar to Classes of antimicrobial agents

Lecture 5- antibiotics.ppt
Lecture 5- antibiotics.pptLecture 5- antibiotics.ppt
Lecture 5- antibiotics.pptAhmanurSule5
 
lecture-5-antibiotics.PowerPoint Presentation
lecture-5-antibiotics.PowerPoint Presentationlecture-5-antibiotics.PowerPoint Presentation
lecture-5-antibiotics.PowerPoint Presentationyamlehtemagallanes88
 
Anti-infective agents1.ppt
Anti-infective agents1.pptAnti-infective agents1.ppt
Anti-infective agents1.pptAmosLangat5
 
Antimicrobials
AntimicrobialsAntimicrobials
Antimicrobialsebinroshan07
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptxKrishna Gandhi
 
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.pptBETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.pptAbdelrhman Abooda
 
Antibiotics resistance
Antibiotics resistanceAntibiotics resistance
Antibiotics resistanceAhmad Ali khan
 
Antibiotic Mechanisms of Action
Antibiotic Mechanisms of ActionAntibiotic Mechanisms of Action
Antibiotic Mechanisms of ActionYazan Kherallah
 
Antibiotics & analgesics dentistry
Antibiotics  & analgesics dentistryAntibiotics  & analgesics dentistry
Antibiotics & analgesics dentistryHema Latha
 
aminoglycosideppt-160110093602.pptx
aminoglycosideppt-160110093602.pptxaminoglycosideppt-160110093602.pptx
aminoglycosideppt-160110093602.pptxAnuradha Mishra
 
Cephalosporine new
Cephalosporine newCephalosporine new
Cephalosporine newTanveerAhmed275
 
antibiotic_classification_and_mechanisms_mhs.pdf
antibiotic_classification_and_mechanisms_mhs.pdfantibiotic_classification_and_mechanisms_mhs.pdf
antibiotic_classification_and_mechanisms_mhs.pdfAgathaHaselvin
 
Antimicrobial Agents and Resistance.pptx
Antimicrobial Agents and Resistance.pptxAntimicrobial Agents and Resistance.pptx
Antimicrobial Agents and Resistance.pptxKrithikaaSekar
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptxmahadevabhu07
 

Similar to Classes of antimicrobial agents (20)

Lecture 02
Lecture 02Lecture 02
Lecture 02
 
Lecture 5- antibiotics.ppt
Lecture 5- antibiotics.pptLecture 5- antibiotics.ppt
Lecture 5- antibiotics.ppt
 
lecture-5-antibiotics.PowerPoint Presentation
lecture-5-antibiotics.PowerPoint Presentationlecture-5-antibiotics.PowerPoint Presentation
lecture-5-antibiotics.PowerPoint Presentation
 
chemo.pptx
chemo.pptxchemo.pptx
chemo.pptx
 
Anti-infective agents1.ppt
Anti-infective agents1.pptAnti-infective agents1.ppt
Anti-infective agents1.ppt
 
Antimicrobials
AntimicrobialsAntimicrobials
Antimicrobials
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
31.ppt
31.ppt31.ppt
31.ppt
 
31.ppt
31.ppt31.ppt
31.ppt
 
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.pptBETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
BETA LACTAM ANTIBIOTICS AND OTHER INHIBITORS OF CELL WALL SYNTHESIS.ppt
 
Antibiotics resistance
Antibiotics resistanceAntibiotics resistance
Antibiotics resistance
 
Antibiotic Mechanisms of Action
Antibiotic Mechanisms of ActionAntibiotic Mechanisms of Action
Antibiotic Mechanisms of Action
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
 
Antibiotics & analgesics dentistry
Antibiotics  & analgesics dentistryAntibiotics  & analgesics dentistry
Antibiotics & analgesics dentistry
 
aminoglycosideppt-160110093602.pptx
aminoglycosideppt-160110093602.pptxaminoglycosideppt-160110093602.pptx
aminoglycosideppt-160110093602.pptx
 
Cephalosporine new
Cephalosporine newCephalosporine new
Cephalosporine new
 
antibiotic_classification_and_mechanisms_mhs.pdf
antibiotic_classification_and_mechanisms_mhs.pdfantibiotic_classification_and_mechanisms_mhs.pdf
antibiotic_classification_and_mechanisms_mhs.pdf
 
Antimicrobial Agents and Resistance.pptx
Antimicrobial Agents and Resistance.pptxAntimicrobial Agents and Resistance.pptx
Antimicrobial Agents and Resistance.pptx
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
 

More from Dr. Geoffrey K. K. Maiyoh

obesity diabetes and metabolic syndrome
obesity diabetes and metabolic syndromeobesity diabetes and metabolic syndrome
obesity diabetes and metabolic syndromeDr. Geoffrey K. K. Maiyoh
 
Dsb 106. intergration of metabolism.2014
Dsb 106. intergration of metabolism.2014Dsb 106. intergration of metabolism.2014
Dsb 106. intergration of metabolism.2014Dr. Geoffrey K. K. Maiyoh
 
Bpt 114. purine and pyrimidine metabolism
Bpt 114. purine and pyrimidine metabolismBpt 114. purine and pyrimidine metabolism
Bpt 114. purine and pyrimidine metabolismDr. Geoffrey K. K. Maiyoh
 
Msp 304. gsd,gout,a cuduria and lesh.2014
Msp 304. gsd,gout,a cuduria and lesh.2014Msp 304. gsd,gout,a cuduria and lesh.2014
Msp 304. gsd,gout,a cuduria and lesh.2014Dr. Geoffrey K. K. Maiyoh
 
Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Dr. Geoffrey K. K. Maiyoh
 
Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Dr. Geoffrey K. K. Maiyoh
 
Chemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionChemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionDr. Geoffrey K. K. Maiyoh
 

More from Dr. Geoffrey K. K. Maiyoh (20)

Cancer in kenya
Cancer in kenyaCancer in kenya
Cancer in kenya
 
Celebrating Kenya
Celebrating KenyaCelebrating Kenya
Celebrating Kenya
 
Lecture 05.2014
Lecture 05.2014Lecture 05.2014
Lecture 05.2014
 
Lecture 04.2014
Lecture 04.2014Lecture 04.2014
Lecture 04.2014
 
Lecture 03.2014
Lecture 03.2014Lecture 03.2014
Lecture 03.2014
 
Lecture 01.2014
Lecture 01.2014Lecture 01.2014
Lecture 01.2014
 
Mineralocorticoids & glucocorticoids
Mineralocorticoids & glucocorticoidsMineralocorticoids & glucocorticoids
Mineralocorticoids & glucocorticoids
 
Molecular diagnostics
Molecular diagnosticsMolecular diagnostics
Molecular diagnostics
 
obesity diabetes and metabolic syndrome
obesity diabetes and metabolic syndromeobesity diabetes and metabolic syndrome
obesity diabetes and metabolic syndrome
 
Dsb 106. intergration of metabolism.2014
Dsb 106. intergration of metabolism.2014Dsb 106. intergration of metabolism.2014
Dsb 106. intergration of metabolism.2014
 
Bpt 114. purine and pyrimidine metabolism
Bpt 114. purine and pyrimidine metabolismBpt 114. purine and pyrimidine metabolism
Bpt 114. purine and pyrimidine metabolism
 
Msp 304. gsd,gout,a cuduria and lesh.2014
Msp 304. gsd,gout,a cuduria and lesh.2014Msp 304. gsd,gout,a cuduria and lesh.2014
Msp 304. gsd,gout,a cuduria and lesh.2014
 
Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014
 
Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)
 
Chemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionChemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introduction
 
ANTIBIOTICS Lecture 06
ANTIBIOTICS Lecture 06ANTIBIOTICS Lecture 06
ANTIBIOTICS Lecture 06
 
ANTIBIOTICS Lecture 05
ANTIBIOTICS Lecture 05ANTIBIOTICS Lecture 05
ANTIBIOTICS Lecture 05
 
Antibiotics Lecture 04
Antibiotics Lecture 04Antibiotics Lecture 04
Antibiotics Lecture 04
 
Antibiotics Lecture 03
Antibiotics Lecture 03Antibiotics Lecture 03
Antibiotics Lecture 03
 
Antibiotics Lecture 01
Antibiotics Lecture 01Antibiotics Lecture 01
Antibiotics Lecture 01
 

Recently uploaded

PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 

Recently uploaded (20)

PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 

Classes of antimicrobial agents

  • 1. MBSM 713: BIOCHEMISTRY OF ANTI MICROBIAL AGENTS Lecture Two: Survey of major antimicrobial drug groups 1.ANTIBACTERIAL AGENTS (Antibiotics) Dr. G. Kattam Maiyoh 01/23/15 1 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 2. Classification: Mode of action 01/23/15 2 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 3. Inhibitors of Cell Wall Synthesis 01/23/15 3 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 4. 01/23/15 4 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02 Bacterial cell wall • There are three types – Gram-positive (e.g. Staphylococci, Listeria • Have many peptidoglycan layers • stains with crystal violet • typically lack the outer membrane found in gram-ve. – Gram-negative (e.g. E.coli, Salmonella) • Have few peptidoglycan layers • (stain safranin or fuchsin) – Acid-fast Positive (Mycobacteria) • Cell wall contains waxy substance (Mycollic acid) • Stains with acid fast (heating required)
  • 5. Antibiotics - Cell wall synthesis inhibitors Beta-lactam antibiotics: 1928 - Alexander Fleming observes the antibacterial effects of Penicillin 1940 - Florey and Chain extract Penicillin 01/23/15 5 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 6. The beta lactams • The β-lactam group of antibiotics includes an enormous diversity of natural and semi-synthetic compounds that inhibit several enzymes associated with the final step of peptidoglycan synthesis. • All of this enormous family are derived from a β -lactam structure: a four-membered ring in which the β -lactam bond resembles a peptide bond. • The multitude of chemical 01/23/15 6 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 8. Penicillinase (β Lactamase) - Represents a great challenge to the action of the beta lactams Figure 20.8 More when we discuss antibiotic resistance 01/23/15 8 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 9. • Penicillium notatum produces the only naturally occurring agent – penicillin G or benzylpenicillin • Penicillium chrysogenum produces 6-aminopenicillanic acid, raw material for semi-synthetics penicillins 01/23/15 9 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 10. Targets for beta lactams 1. The targets for β-lactam drugs are the penicillin binding proteins (PBP's), so called because they bind radioactive penicillin and can be detected by autoradiography of gels on which bacterial proteins have been separated electrophoretically. • The penicillin binding proteins have transpeptidase or carboxypeptidase activity and they act to regulate cell size and shape. • They are also involved in septum formation and cell division. Bacteria have several individual penicillin binding proteins, each with a separate function. • Conventionally these are numbered according to size, with PBP 1 as the largest protein. • The PBP 1 of one bacterium will not necessarily have the same function as the PBP 1 of a different organism. 01/23/15 10 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 11. Target 2. The β-lactam antibiotics also stimulate the activity of autolysins by inactivating an inhibitor => lysis • Autolysins are enzymes that are responsible for the natural turnover of cell wall polymers to permit growth of the cells. • Under normal conditions, these enzymes produce controlled weak points within the peptidoglycan structure to allow for expansion of the cell wall structure. • This activity is stimulated by β-lactams, causing a breakdown of peptidoglycan and leading to osmotic fragility of the cell and ultimately to cell lysis. 01/23/15 11 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 12. Penicillins - classification – Narrow spectrum – penicillinase sensitive – Narrow spectrum – penicillinase resistant – Broad spectrum penicillins – Extended-spectrum penicillins • Cephalosporines • Carbapenems • Monobactams • Vancomycin, Bacitracin 01/23/15 12 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 13. Penicllins (pharmacokinetics) • Attains therapeutic concentration in most tissues • However has poor CSF penetration • Renal excretion (Excretion) • Side effects: hypersensitivity, nephritis, neruotoxicity, platelet dysfunction 01/23/15 14 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 14. Narrow spectrum – penicillinase (= β-lactamase) sensitive • Benzylpenicillin – Naturally occuring – Poor oral availability (sensitive to stomach acid) => given by injection – Active against gram-positive bacteria • Phenoxymethylpenicillin – Better oral availability (acid resistant) 01/23/15 15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 15. Narrow spectrum – penicillinase (= β-lactamase) resistant • Methicillin – Semisynthetic – Poor oral availability (only parenteral) – Active against gram-pos bacteria – Mostly used for Staphylococcus aureus • Oxacillin – Good oral availability • Cloxacillin • Dicloxacillin 01/23/15 16 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 16. Broad spectrum – penicillinase (β- lactamase) sensitive (Also referred to as Aminopenicillins) • Ampicillin – Semisynthetic – Good oral availability – Active against gram-pos and gram-neg bacteria – Active against enterobacteria e.g. kleb. Shig. Salm • Amoxicillin – Excellent oral availability 01/23/15 17 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 17. Extended spectrum – penicillinase (β- lactamase) sensitive (Also called Carboxypenicillins) • Carbenicillin – Semisynthetic – Poor oral availability – Active against gram-pos and gram-neg bacteria – Active against Pseudomonas aeruginosa and Klebsiella • Ticarcillin • Mezlocillin • Pipercillin 01/23/15 18 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 20. Cephalosporins • Share the same antibiotic mechanism as penicillins • Cross-allergies with penicillins are common • Some CSs antagonize Vitamin K => leads to bleeding • Some CSs block alcohol oxidation => disulfiram effect (allergic reactions, seizures, extreme tiredness and dark urine) Classified into generations: 1- 4  • Increasing activity against gram-negative bacteria and anaerobes • Increasing resistance to destruction by beta-lactamases • Increasing ability to reach cerebrospinal fluid 01/23/15 21 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 21. Cephalosporins • The first to be discoverded were called first generation while later, more extended spectrum cephalosporins were classified as second, third and 4th generation cephalosporins in this order. • Each newer generation has significantly greater gram- negative antimicrobial properties than the preceding generation, • Most cases with decreased activity against gram- positive organisms. • Fourth generation cephalosporins, however, have true broad spectrum activity. 01/23/15 22 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 24. • Base molecule is 7- aminocephalosporanic acid produced by a Sardinian sewer mold • R groups determine spectrum of activity and pharmacological properties • Mechanism of action/resistance and class pharmacology is essentially the same as penicillins 01/23/15 25 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 25. First Generation Cephalosporins • Cefazolin, cephalexin, cephadroxil • Excellent against susceptible staph and strep • Modest activity against G -ve • Cefazolin given parentally, others orally • More than half of the drug is bound to plasma proteins • Excreted by kidneys unmetabolized • Good for staph and strep skin and soft tissue infections 01/23/15 26 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 26. Second Generation Cephalosporins • Include; – Cefaclor, – cefuroxime, – cefprozil • Modest activity against G+, increased activity against G-, works against anaerobes • Cefaclor and cefprozil given orally • Absorption and excretion same as first generation. • Good for treating respiratory tract infections, intra-abdominal infections, pelvic inflammatory disease, diabetic foot ulcers 01/23/15 27 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 27. Third Generation Cephalosporins • Ceftaxime, ceftriaxzone, cefoperazone, cefpodoxime • Broad spectrum killers • Drugs of choice for serious infections • No effect against Listeria and beta- lactamase producing pneumococci • Cefpodoxime given orally, others parentally • Most excreted by kidney • Therapeutic uses – Bacterial meningitis – Lyme disease – Life-threatening G -ve sepsis (infection) 01/23/15 28 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 28. Fourth Generation Cephalosporin – e.g.Cefepime –Have true broad spectrum activity ( and more beta-lactamases resistanc (effective against Gm+ and Gm-) –Given parentally, excellent penetration into CSF –Good for nosocomial infections 01/23/15 29 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 30. Toxicity/Contraindications of Cephalosporins • Hypersensitivity reactions (uncommon) essentially same as for penicillins • Cross-reaction between 2 classes 01/23/15 31 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 31. Inhibitors of Cell Wall Synthesis 01/23/15 33GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 32. Carbapenems • Beta-lactam ring is fused to a 5 member ring system • Effect on microbes and pharmacology of carbapenems similar to penicillins 01/23/15 34GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 33. Selected Carbapenems • Imipenem – Broad spectrum including anaerobes and Pseudomonas aeruginosa – Parentally administered – Must be combined with cilastatin to be absorbed – Excreted by kidneys • Meropenem, ertapenem, and doripenem are similar to imipenem but don’t need co- administration with cilastatin cilastatin chemical compound which inhibits the human enzyme dehydropeptidase 01/23/15 35GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 34. Toxicity/Contraindications of Carbapenems • Nausea and vomiting (common) • Hypersensitivity reactions (uncommon) – Essentially the same as for penicillins – Cross-reactivity is possible 01/23/15 36 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 35. Aztrenam – a monobactam • Monobactam - beta-lactam compounds wherein the beta-lactam ring is alone and not fused to another ring • Works only on Gm -ve, including Pseudomonas aeruginosa • Useful for treating G-ve infections that require a beta-lactam because it does not elicit hypersensitivity reactions 01/23/15 37GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 36. Beta-lactamase inhibitors a. Clavulanic acid – Irreversible inhibitor of β-lactamase – Good oral absorption – Combined with amoxicillin or ticarcillin b. Sulbactam 01/23/15 38GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 37. Peptide Antibiotics Peptide antibiotics are drugs with polypeptides structure Sub-group of Peptide Antibiotics Polymyxins e.g. ÂťPolymyxin B ÂťColistin Glycopeptides e.g. ÂťVancomycin ÂťTeicoplanin ÂťAvoparcin Bacitracin Streptogramins Each drug group has its own mechanism of action 4 groups and 4 mechanism 01/23/15 39 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 38. PolymyxinsPolymyxins Drug members Polymyxin B Colistin (Polymyxin E) Mechanism of action Detergent-like action Damage to cell membrane function Bind to Lipopolysaccharides (LPS) and destroy outer membrane of Gram- negative bacteria Bactericidal Concentration-dependent Non-selective on bacterial membrane Spectrum of activity Gram-negative bacteria01/23/15 40 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 39. PolymyxinsPolymyxins • Pharmacokinetics –Not absorbed via GI tract –If injection, drug accumulated and slowly excreted • Toxicities –Highly toxic if systemic injection –Nephrotoxic –Neurotoxic • Clinical uses –Oral treatment – 01/23/15 41 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 40. GlycopeptidesGlycopeptides • Group members –Vancomycin • Antibacterial activity –Inhibition of cell wall synthesis –Active against Gram-positive bacteria • Not absorbed orally, must administered IV • High toxicity –Local irritation , ototoxicity, nephrotoxicity • Clinical uses –Hardly used in animals01/23/15 42 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 41. BacitracinBacitracin • Drug activity –Inhibit cell wall synthesis –Activity on Gram-positive bacteria –Bactericidal • Nephrotoxic if systemic injection • Clinical uses – the same as polymyxin –Oral – as growth promoter –Local or topical drugs 01/23/15 43 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 42. Antibiotics that Inhibit Protein Synthesis 01/23/15 44 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 43. Protein synthesis inhibitors – Aminoglycosides – Tetracyclins - Spectinomycin – Macrolides – Chloramphenicol – Clindamycin 01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02 45
  • 44. Inhibition of Protein Synthesis by Antibiotics Figure 20.4 01/23/15 46 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 45. Review of Initiation of Protein Synthesis 30S 1 3 2 GTP 1 2 3 GTP Initiation Factors mRNA 3 1 2 GTP 30S Initiation Complex f-met-tRNA Spectinomycin Aminoglycosides 1 2 GDP + Pi 50S 70S Initiation Complex AP 01/23/15 47 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 46. Review of Elongation of Protein Synthesis GTP AP Tu GTP Tu GDP Ts Ts Tu + GDP Ts Pi P ATetracycline AP Erythromycin Fusidic Acid Chloramphenicol G GTP G GDP + Pi G GDP AP + GTP 01/23/15 48 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 47. Antimicrobials that Bind to the 30S Ribosomal Subunit 01/23/15 49 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 48. a) Aminoglycosides (bactericidal) streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, neomycin (topical) • Mode of action - The aminoglycosides irreversibly bind to the 16S ribosomal RNA and freeze the 30S initiation complex (30S-mRNA-tRNA) so that no further initiation can occur. • They also slow down protein synthesis that has already initiated and induce misreading of the mRNA. – By binding to the 16 S r-RNA the aminoglycosides increase the affinity of the A site for t-RNA regardless of the anticodon specificity. • May also destabilize bacterial membranes. 01/23/15 50 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 49. Microbe Library American Society for Microbiology www.microbelibrary.org 01/23/15 51 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 50. b) Aminoglycosides (bactericidal) streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, neomycin (topical) • Spectrum of Activity –Effective against many gram- negative and some gram-positive bacteria; • Not useful for anaerobic (oxygen required for uptake of antibiotic) or intracellular bacteria. • Resistance - Common • Synergy - The aminoglycosides synergize with β -lactam antibiotics. The β -lactams inhibit cell wall synthesis and thereby increase the permeability of the aminoglycosides. 01/23/15 52GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 51. c) Tetracyclines (bacteriostatic) tetracycline, minocycline and doxycycline • Mode of action - The tetracyclines reversibly bind to the 30S ribosome and inhibit binding of aminoacyl-t-RNA to the acceptor site on the 70S ribosome. • Spectrum of activity - Broad spectrum; Useful against intracellular bacteria • Resistance - Common • Adverse effects - Destruction of normal intestinal flora resulting in increased secondary infections; staining and impairment of the structure of bone and teeth. 01/23/15 53 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 52. d) Spectinomycin (bacteriostatic) • Mode of action - Spectinomycin reversibly interferes with m-RNA interaction with the 30S ribosome. It is structurally similar to the aminoglycosides but does not cause misreading of mRNA. • Spectrum of activity - Used in the treatment of penicillin-resistant Neisseria gonorrhoeae • Resistance - Rare in Neisseria gonorrhoeae 01/23/15 54 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 53. Antimicrobials that Bind to the 50S Ribosomal Subunit 01/23/15 55 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 54. a) Chloramphenicol, Lincomycin, Clindamycin (bacteriostatic) • Mode of action - These antimicrobials bind to the 50S ribosome and inhibit peptidyl transferase activity. • Spectrum of activity - Chloramphenicol - Broad range; Lincomycin and clindamycin - Restricted range • Resistance - Common • Adverse effects - Chloramphenicol is toxic (bone marrow suppression) but is used in the treatment of bacterial meningitis. 01/23/15 56 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 55. b) Macrolides (bacteriostatic) erythromycin, clarithromycin, azithromycin, spiramycin • Mode of action - The macrolides inhibit translocation. • Spectrum of activity - Gram-positive bacteria, Mycoplasma, Legionella • Resistance - Common 01/23/15 57 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 56. Macrolides : ClassificationMacrolides : Classification • Macrolides are drugs with lactone ring structure • Sub-groups are based on no. of ring atom – 12-membered ring macrolides – 13-membered – 14-membered (many drugs) – 15-membered – 16-membered (many drugs) • Special groups – Azalides – name for 15-membered – Triamilides – name for tulathromycin (combination of 13- and 15-membered) – Ketolides – name for 14-membered with 3 keto group 01/23/15 58 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 57. MacrolidesMacrolides Drug examples 13-membered Tulathromycin (Triamilides) 14-membered Erythromycin Clarithromycin, Roxithromycin, Dirithromycin 15-membered Azithromycin (Azalides) Tulathromycin (Triamilides) 16-membered Spiramycin Tylosin 01/23/15 59 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 58. Macrolides – generalMacrolides – general propertiesproperties • Mechanism of action – Inhibit protein synthesis – Bind to 50S ribosomal unit – Bacteriostatic • Spectrum of activity – Gram-positive – Some Gram- negative 01/23/15 60 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 59. MacrolidesMacrolides Pharmacokinetics Broad distribution in body tissues High intracellular concentration 01/23/15 61 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 60. MacrolidesMacrolides Additional properties of Macrolides • Anti-inflammatory effect – Inhibitory effect on neutrophils – inhibit proinflammatory cytokines – Useful for treatment of inflammatory01/23/15 62 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 61. ErythromycinErythromycin • Erythromycin is a standard or basic drug of macrolides • Other drug members are usually compared with erythromycin • Important adverse effect - severe diarrhea – Especially in adult horse and ruminants • Clinical uses – Second choice (alternative drug) in humans – Small animals – Fowls 01/23/15 63 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 62. Tylosin andTylosin and SpiramycinSpiramycin • Tylosin and Spiramycin – Activities are similar to erythromycin – Good activity on Mycoplasma • Examples of Clinical uses – Whooping couph – Pneumonia – VDs – Used in ruminants01/23/15 64 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 63. Advanced generationAdvanced generation MacrolidesMacrolides Example drugs Roxithromycin Dirithromycin Clarithromycin Azithromycin General activity – the same as erythromycin Better Pharmacokinetic properties Acid stable Fewer GI side effect Higher oral availability Longer serum half-lives Higher tissue concentrations 01/23/15 65 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 64. KetolidesKetolides • Ketolides are 14- membered ring macrolides with 3 keto group • Specific drugs – Telithromycin – Cethromycin (still in clinical study) • Important properties – Less resistance – Good activities on01/23/15 66 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 65. Fusidic acid (bacteriostatic) • Selectivity due to differences in prokaryotic and eukaryotic elongation factors • Mode of action - Fusidic acid binds to elongation factor G (EF-G) and inhibits release of EF-G from the EF-G/GDP complex. • Spectrum of activity - Gram-positive cocci 01/23/15 67GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02 Antimicrobials that Interfere with Elongation Factors
  • 66. Inhibitors of Nucleic Acid Synthesis ~Inhibitors of DNA synthesis ~Inhibitors of RNA synthesis 01/23/15 69 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 67. Inhibitors of RNA Synthesis For this class of antibiotics, selectivity is due to differences between prokaryotic and eukaryotic RNA polymerase i.e. All RNA polymerases are multi-protein complexes, however, the number of proteins that are assembled to form the active enzyme is much larger in eukaryotes; •The basic catalytic core is made up of 12 subunits. •By comparison, bacterial RNAP has 5 subunits. 01/23/15 70 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 68. Rifampin, Rifamycin, Rifampicin, Rifabutin (bactericidal) • Mode of action - These antimicrobials bind to DNA-dependent RNA polymerase and inhibit initiation of mRNA synthesis. • Spectrum of activity - Broad spectrum but is used most commonly in the treatment of tuberculosis • Resistance – Common – For example; – Resistance to rifampicin develops quickly during treatment, so monotherapy should not be used to treat these infections — it should be used in combination with other antibiotics. – Resistance to rifampicin arises from mutations that alter residues of the rifampicin binding site on RNA polymerase, resulting in decreased affinity for rifampicin. • Combination therapy - Since resistance is common, rifampin is usually used in combination therapy. 01/23/15 71 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 69. Inhibitors of DNA Synthesis For this class of antibiotics, selectivity due to differences between prokaryotic and eukaryotic DNA replication enzymes Consider the following: Eukaryotic replication is more complicated. •First, they have multiple ori per chromosome that allow for bidirectional synthesis of the linear chromosome. •They also use several DNA polymerases (I, II, III), and ligase (seals the nicks in the DNA strand), and RNA primer (gives a 3' end for the DNA polymerase to start synthesis). •As for other differences in their synthesis of DNA is their speed, prokaryotes can replicate their chromosome at about 1,000 bp/sec, while eukaryotes can replicate their chromosomes at about 100 bp/sec. •They also differ in the number of ori, eukaryotes (as it was stated above) has multiple ori, while prokaryotes have only one. 01/23/15 72 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 70. The Quinolones • Current drugs are fluoridated 4-quinolones • Broad coverage (some broader than others) • Targets DNA gyrase ( G-) and topoisomerase IV (G+) • Resistance due to efflux and mutations in targets 01/23/15 73 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 71. Pharmacological attributes of Quinolones • Favorable pharmacological attributes – Orally administered, quickly absorbed, even with a full stomach – Excellent bioavailability in a wide range of tissues and body fluids (including inside cells) • Mostly cleared by the kidneys – Exceptions are pefloxacin and moxifloxacin which are metabolized by liver • Ciprofloxacin, ofloxacin, and pefloxacin are excreted in breast milk ““Got Cipro?”Got Cipro?” 01/23/15 74 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 72. Therapeutic Uses of Quinolones • Urinary tract infections • Prostatitis • STD’s – Chlamydia – Chancroid - painful sores on the genitalia – Not syphilis or gonorrhea (due to increased resistance) 01/23/15 75 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 73. Therapeutic Uses of Quinolones • GI and abdominal – Travelers diarrhea – Shigellosis – Typhoid fever • Respiratory tract – New agents for strep. pneumonia 01/23/15 76 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 74. Therapeutic Uses of Quinolones • Bone, joint, soft tissue – Ideal for chronic osteomylitis - infection of the bone or bone marrow • Resistance developing in S. aureus, P. aeruginosa, and S. marcesens – Good against polymicrobial infections like diabetic foot ulcers 01/23/15 77 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 75. Therapeutic Uses of Quinolones • Ciprofloxacin for anthrax and tuleremia (rabbit fever, deer fly fever, Ohara's fever) • Combined with other drugs, useful for atypical Mycobacterium sp. Pulmonary AnthraxPulmonary Anthrax 01/23/15 78 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 76. Toxicity/Contraindications of Quinolones • Nausea, vomiting, abdominal discomfort (common) • Diarrhea and antibiotic-associated colitis (uncommon to rare) • CNS side effects – Mild headache and dizziness (common to rare) – Hallucinations, delirium, and seizures (rare) • Arthropy in immature animals (common) – Quinolones not given to children unless benefits outweigh the risks • Leukopenia, eosinophilia, heart arythmias (rare) delirium - disorder involving incoherent speech, hallucinations, etc., caused by intoxication, fever, etc 01/23/15 79 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 78. Inhibitors of Folic Acid Synthesis • Basis of Selectivity • Review of Folic Acid Metabolism p-aminobenzoic acid + Pteridine Dihydropteroic acid Dihydrofolic acid Tetrahydrofolic acid Pteridine synthetase Dihydrofolate synthetase Dihydrofolate reductase Thymidine Purines Methionine Trimethoprim Sulfonamides 01/23/15 81 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 79. Sulfonamides, Sulfones (bacteriostatic) • Mode of action - These antimicrobials are analogues of para- aminobenzoic acid and competitively inhibit formation of dihydropteroic acid. • Spectrum of activity - Broad range activity against gram- positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections. • Resistance - Common • Combination therapy - The sulfonamides are used in combination with trimethoprim; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains. 01/23/15 82 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 80. Trimethoprim, Methotrexate, Pyrimethamine (bacteriostatic) • Mode of action - These antimicrobials binds to dihydrofolate reductase and inhibit formation of tetrahydrofolic acid. • Spectrum of activity - Broad range activity against gram- positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections. • Resistance - Common • Combination therapy - These antimicrobials are used in combination with the sulfonamides; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains. 01/23/15 83 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 81. Sulfonamides • Analogues of para-aminobenzoic acid • Broad spectrum • Competitive inhibitors of dihydropteroate synthase – needed for folic acid synthesis Gerhard Domagk gets a NobelGerhard Domagk gets a Nobel for Medicine, 1939.for Medicine, 1939. 01/23/15 84 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 82. Sulfonamides • Mostly absorbed from GI tract • Binds variably to serum albumin • Wide tissue distribution, including transplacentally • Variably inactivated in liver by acetylation and then excreted in urine • Some agents can precipitate in acid urine 01/23/15 85 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 83. 1. Rapidly Absorbed and Eliminated Sulfonamides • Sulfisoxazole, sulfamethoxazole, sulfadiazine • Bind extensively to plasma proteins • Highly concentrated in urine (cidal) • Sulfamethoxazole combined with trimethoprim (Bactrim) is widely used to treat a variety of infections (esp. UTI) 01/23/15 86 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 84. 2. Poorly Absorbed Sulfonamides • E.g. Sulfasalazine • Poorly absorbed in GI tract • Used to treat ulcerative colitis and irritable bowel syndrome • Gut flora metabolize drug into 2 compounds, 1 toxic- sulfapyridine, 1 therapeutic (5-aminosalicylate) • Hence is a prodrug – effective after breakdown Ulcerative Colitis 01/23/15 87 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 85. Sulfonamides for Topical Use • E.g. 1.Sulfacetamide – Good penetration in eye – Non-irritating • 2. Silver sulfadiazine – Prevention and treatment of burn wound infections Bacterial corneal infectionBacterial corneal infection 01/23/15 88 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 86. Long Acting Sulfonamide • Serum half-life is measured in days rather than minutes or hours • E.g. Sulfadoxine • Combined with pyirethamine to treat malaria Plasmodium vivaxPlasmodium vivax 01/23/15 89 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 87. Therapeutic Uses of Sulfonamides • Urinary tract infections • Nocardiosis -serious infection caused by a fungus-like bacterium that begins in the lungs and can spread to the brain. • Toxoplasmosis - caused by protozoan (avoid using in pregnant women) Nocardia asteroidesNocardia asteroides 01/23/15 90 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 88. Toxicity/Contraindications of Sulfonamides - UT • Crystallization in acid urine – Common to uncommon depending on drug. – Alkalize urine or increase hydration 01/23/15 91 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 89. Toxicity/Contraindications of Sulfonamides - blood • Acute hemolytic anemia – Rare to extremely rare – Associated with glucose-6-phosphate dehydrogenase activity in RBC • Agranulocytosis - failure of the bone marrow to make enough white blood cells (neutrophils). (extremely rare) • Aplastic anemia - marrow doesn't make enough new blood cells. (extremely rare) 01/23/15 92 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 90. Toxicity/Contraindications of Sulfonamides - immune • Hypersensitivity reactions (common to uncommon) – Skin and mucous membrane manifestations (rashes) – Serum sickness - type III hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum – Focal or diffuse necrosis of the liver (rare) 01/23/15 93 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 91. Toxic Epidermal Necrolysis (TEN) 01/23/15 94 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 92. Toxicity/Contraindications of Sulfonamides - miscellaneous • Nausea, anorexia, vomiting (common) • Kernicterus; damage caused by excessive jaundice – Displacement of bilirubin from plasma albumin to brain resulting in encephalopathy(disease of the brain) – Never give sulfa drugs to a pregnant or lactating woman • Potentiation of oral coagulants, sulfonylurea hypoglycemic drugs, and hydrantoin anticonvulsants Bilirubin deposits in neonatalBilirubin deposits in neonatal brainbrain 01/23/15 95 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
  • 93. INJURY TO THE PLASMA MEMBRANE - Brief • All cells are bound by a cell membrane. • And although the membranes of all cells are quite similar, those of bacteria and fungi differ from eukaryotic cells. • These slight differences allow for selective action of some antimicrobial agents. • Certain antibiotics, like polymyxins, act as detergents to dissolve bacterial cell membranes by binding to phospholipids present in the membranes. 01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02 96
  • 94. The End Thank you for Listening 01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02 97